Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data

Summary by CNBC
Eli Lilly's Daniel Skovronsky talks the latest orforglipron trial, while UnitedHealth Group CEO Stephen Hemsley is moving quickly on a strategic turnaround.

3 Articles

CNBCCNBC
Center

Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data

Eli Lilly's Daniel Skovronsky talks the latest orforglipron trial, while UnitedHealth Group CEO Stephen Hemsley is moving quickly on a strategic turnaround.

·United States
Read Full Article
Busines and Oil NewsBusines and Oil News

Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data – DG Verifications & Stats

Open the article to view the coverage from Busines and Oil News

Read Full Article
ramaonhealthcare.comramaonhealthcare.com

Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data – RamaOnHealthcare

Eli Lilly's closely watched obesity pill is inching closer to entering the market. The drug, orforglipron, succeeded in another late-stage trial, helping

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

CNBC broke the news in United States on Tuesday, August 26, 2025.
Sources are mostly out of (0)

Similar News Topics

Eli Lilly icon

Eli Lilly

Medical icon

Medical

UnitedHealth icon

UnitedHealth

News
For You
SearchBlindspotLocal